Latest Valsartan Stories
FORT LAUDERDALE-DAVIE, Fla., Feb. 2, 2015 /PRNewswire/ -- Millions of people take angiotensin receptor blockers (ARBs) to help treat heart failure.
MUMBAI and BALTIMORE, January 6, 2015 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc.
PITTSBURGH, Jan. 5, 2015 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S.
DUBLIN, Dec. 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the Company has received a complete response letter from the U.S.
CHAPEL HILL, N.C., Nov. 14, 2014 /PRNewswire/ -- In 1997, Novartis launched its antihypertension treatment Diovan into a crowded marketplace.
WOODCLIFF LAKE, N.J., Sept. 30, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc.
Dr. Milton Packer and Dr. McMurray will be presenting these results for the first time in the United States at the HFSA Annual Meeting LAS VEGAS, Sept.
DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the U.S.
Receives first-to-file FDA approval, with 180-day marketing exclusivity for generic version in the treatment of hypertension and heart failure NEW BRUNSWICK, N.J., June 27, 2014 /PRNewswire/
ChinaMarketResearchReports.com adds Latest Report on “Investigation Report on China Valsartan Market, 2009-2018” to its store. Dallas, TX (PRWEB) February
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.